It was recently reported that hypoxia-induced ROS augment the hypoxic adaptation of glioblastoma by mediating the HIF-1α-SERPINE1 signaling pathway, making ROS a promising therapeutic target for glioblastoma [202]. The gene discussed is SERPINE1; the disease is glioblastoma.